Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Huey

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Oncologist|April 27, 2023
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated CancersVan K Morris, Amir Jazaeri, Shannon N Westin, et al.
NPJ Precision Oncology|February 5, 2025
BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapyVinay K Pattalachinti, Emaan Haque, Mahmoud Yousef, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Biethnic comparisons of autosomal genomic scan for loci linked to plasma adiponectin in populations of Chinese and Japanese originLee-Ming Chuang, Yen-Feng Chiu, W Huey-Herng Sheu, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 29, 2021
A study of 3013 cases of hepatocellular carcinoma: Etiology and therapy before and during the current decadeMiao-Shan Lim, George B-B Goh, Jason P-E Chang, et al.
The Journal of Surgical Research|February 9, 2021
Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care InitiativeCasey J Allen, Jarrod S Eska, Nikhil G Thaker, et al.
Journal for Immunotherapy of Cancer|May 26, 2022
Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trialKanwal P Raghav, Bettzy Stephen, Daniel D Karp, et al.
Annals of Surgery|March 20, 2024
Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic CancerSamuel H Cass, Ching-Wei D Tzeng, Laura R Prakash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2021
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown PrimaryKanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, et al.
The Oncologist|March 30, 2021
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical TrialsRyan W Huey, Goldy C George, Penny Phillips, et al.
Clinical and Translational Radiation Oncology|March 5, 2021
Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite networkAlexander Augustyn, Valerie I Reed, Neelofur Ahmad, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Oncologist|April 27, 2023
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated CancersVan K Morris, Amir Jazaeri, Shannon N Westin, et al.
NPJ Precision Oncology|February 5, 2025
BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapyVinay K Pattalachinti, Emaan Haque, Mahmoud Yousef, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Biethnic comparisons of autosomal genomic scan for loci linked to plasma adiponectin in populations of Chinese and Japanese originLee-Ming Chuang, Yen-Feng Chiu, W Huey-Herng Sheu, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 29, 2021
A study of 3013 cases of hepatocellular carcinoma: Etiology and therapy before and during the current decadeMiao-Shan Lim, George B-B Goh, Jason P-E Chang, et al.
The Journal of Surgical Research|February 9, 2021
Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care InitiativeCasey J Allen, Jarrod S Eska, Nikhil G Thaker, et al.
Journal for Immunotherapy of Cancer|May 26, 2022
Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trialKanwal P Raghav, Bettzy Stephen, Daniel D Karp, et al.
Annals of Surgery|March 20, 2024
Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic CancerSamuel H Cass, Ching-Wei D Tzeng, Laura R Prakash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2021
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown PrimaryKanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, et al.
The Oncologist|March 30, 2021
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical TrialsRyan W Huey, Goldy C George, Penny Phillips, et al.
Clinical and Translational Radiation Oncology|March 5, 2021
Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite networkAlexander Augustyn, Valerie I Reed, Neelofur Ahmad, et al.
Pageof 3